HomeBGA • CVE
add
BioNeutra Global Corp
Previous close
$0.030
Year range
$0.0050 - $0.16
Market cap
1.39M CAD
Avg Volume
67.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.05M | 20.35% |
Operating expense | 1.12M | -9.87% |
Net income | -412.24K | 69.14% |
Net profit margin | -13.52 | 74.35% |
Earnings per share | — | — |
EBITDA | -228.58K | -202.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 796.54K | 0.60% |
Total assets | 13.57M | -14.00% |
Total liabilities | 21.81M | -6.34% |
Total equity | -8.23M | — |
Shares outstanding | 41.22M | — |
Price to book | -0.15 | — |
Return on assets | -5.00% | — |
Return on capital | 152.79% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -412.24K | 69.14% |
Cash from operations | 33.44K | -90.47% |
Cash from investing | -13.26K | -287.95% |
Cash from financing | -225.05K | -192.82% |
Net change in cash | 441.30K | 33.79% |
Free cash flow | -54.07K | -104.46% |
About
Founded
1996
Headquarters
Website
Employees
51
